Lv51
1386 积分 2022-07-11 加入
Tumor DNA methylation subtypes predict immunotherapy outcomes in pleural mesothelioma patients in the NIBIT-EPI-MESO study
2小时前
待确认
Methylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapy
7小时前
已完结
Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial
9天前
已完结
Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial
11天前
已完结
Dynamic transitioning between MAPK-driven and WNT-driven cell states drives intestinal cancer and shapes therapy response
13天前
已完结
Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial
16天前
已完结
Endocytic evasion confers resistance to antibody-drug conjugates therapy in cancer
1个月前
已完结
Circulating cell-free DNA-based multi-cancer early detection
1个月前
已完结
Risk-adaptive Therapy Guided by Dynamic ctDNA in Nasopharyngeal Carcinoma
1个月前
已完结
Multi-omic characterization of nasopharyngeal carcinoma delineates the subtype-specific landscape of response to induction chemotherapy
1个月前
已完结
皖公网安备34019202002308
